Psilocybin and Subjective Experience Study
Treatments studied
Part of Injuries & trauma clinical trials.
This study looks at how psilocybin affects people's subjective experience. It aims to understand the mind-altering effects of this psychedelic compound in healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Be able to read and write in English
- No current or past psychiatric conditions like depression, anxiety, bipolar disorder, or psychosis
- No family history of schizophrenia or bipolar disorder in close relatives
- Not taking certain medications like antidepressants (SSRIs, SNRIs, MAO inhibitors) or antipsychotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.
Hear when a new Investigating the Importance of the Subjective Psychedelic Experience trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.